The Skin |
Last updated (19 November 2003) |
|
|
There is no evidence that adjuvant radiotherapy to the draining lymph nodes is of any benefit.
Neither topical or systemic 5-fluro-uracil is beneficial in the adjuvant setting.
BCG is of no benefit in squamous cancer of the skin. It is used to treat patients with bladder cancer.
Antibodies designed to block the epidermal growth factor receptor have been found to be useful in patients with certain types of breast cancer. To date there is no evidence that they are of any use in squamous skin cancer.